Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 91

1.

Using a Mendelian randomization approach to explore a causal relationship between vitamin D and nonmelanoma skin cancer.

Kim Y, Kraft P, Asgari MM.

Br J Dermatol. 2018 Jun;178(6):1241-1242. doi: 10.1111/bjd.16599. No abstract available.

PMID:
29897124
2.

Genetic variants in the HLA class II region associated with risk of cutaneous squamous cell carcinoma.

Wang W, Ollila HM, Whittemore AS, Demehri S, Ioannidis NM, Jorgenson E, Mignot E, Asgari MM.

Cancer Immunol Immunother. 2018 May 12. doi: 10.1007/s00262-018-2168-2. [Epub ahead of print]

PMID:
29754218
3.

Photosensitizing Antihypertensive Drug Use and Risk of Cutaneous Squamous Cell Carcinoma.

Su KA, Habel LA, Achacoso NS, Friedman GD, Asgari MM.

Br J Dermatol. 2018 May 3. doi: 10.1111/bjd.16713. [Epub ahead of print]

PMID:
29723931
4.

Common Mitochondrial Haplogroups and Cutaneous Squamous Cell Carcinoma Risk.

Jorgenson E, Choquet H, Yin J, Asgari MM.

Cancer Epidemiol Biomarkers Prev. 2018 Apr 25. doi: 10.1158/1055-9965.EPI-18-0236. [Epub ahead of print]

PMID:
29695379
5.

How data can deliver for dermatology.

Abuabara K, Asgari MM, Chen SC, Dellavalle RP, Kalia S, Secrest AM, Silverberg JI, Solomon JA, Weinstock MA, Wu JJ, Chren MM; Epidemiology Expert Research Group.

J Am Acad Dermatol. 2018 Mar 21. pii: S0190-9622(18)30470-5. doi: 10.1016/j.jaad.2018.03.020. [Epub ahead of print] No abstract available.

PMID:
29574090
6.

Quantifying the Polygenic Contribution to Cutaneous Squamous Cell Carcinoma Risk.

Sordillo JE, Kraft P, Wu AC, Asgari MM.

J Invest Dermatol. 2018 Feb 13. pii: S0022-202X(18)30116-7. doi: 10.1016/j.jid.2018.01.031. [Epub ahead of print]

PMID:
29452120
7.

Use of antihypertensive drugs and risk of keratinocyte carcinoma: A meta-analysis of observational studies.

Tang H, Fu S, Zhai S, Song Y, Asgari MM, Han J.

Pharmacoepidemiol Drug Saf. 2018 Mar;27(3):279-288. doi: 10.1002/pds.4384. Epub 2018 Jan 10.

PMID:
29318704
8.

A real-world, community-based cohort study comparing the effectiveness of topical fluoruracil versus topical imiquimod for the treatment of actinic keratosis.

Neugebauer R, Levandoski KA, Zhu Z, Sokil M, Chren MM, Friedman GD, Asgari MM.

J Am Acad Dermatol. 2018 Apr;78(4):710-716. doi: 10.1016/j.jaad.2017.12.042. Epub 2017 Dec 24.

PMID:
29277731
9.

Herpes Zoster Rates in a Large Cohort of Patients With Systemically Treated Psoriasis.

Levandoski KA, Quesenberry CP, Tsai AL, Asgari MM.

JAMA Dermatol. 2018 Feb 1;154(2):218-219. doi: 10.1001/jamadermatol.2017.4840. No abstract available.

PMID:
29261840
10.

Reply to: Comment on "Serious infections among a large cohort of subjects with systemically treated psoriasis".

Dobry AS, Quesenberry CP, Asgari MM.

J Am Acad Dermatol. 2018 May;78(5):e115. doi: 10.1016/j.jaad.2017.12.017. Epub 2017 Dec 14. No abstract available.

PMID:
29247684
11.

Organ transplantation and cutaneous squamous cell carcinoma: progress, pitfalls and priorities in immunosuppression-associated keratinocyte carcinoma.

Harwood CA, Arron ST, Proby CM, Asgari MM, Bouwes Bavinck JN, Green AC, Toland AE; KeraCon Consortium.

Br J Dermatol. 2017 Nov;177(5):1150-1151. doi: 10.1111/bjd.15932. No abstract available.

PMID:
29192981
12.

Research gaps in the management and prevention of cutaneous squamous cell carcinoma in organ transplant recipients.

Blomberg M, He SY, Harwood C, Arron ST, Demehri S, Green A, Asgari MM; NCI Keratinocyte Carcinoma Consortium.

Br J Dermatol. 2017 Nov;177(5):1225-1233. doi: 10.1111/bjd.15950. Epub 2017 Oct 30. Review.

PMID:
29086412
13.

Susceptibility Loci-Associated Cutaneous Squamous Cell Carcinoma Invasiveness.

Wang W, Jorgenson E, Whittemore AS, Asgari MM.

J Invest Dermatol. 2018 Mar;138(3):557-561. doi: 10.1016/j.jid.2017.09.034. Epub 2017 Oct 17.

PMID:
29054604
14.

Towards the use of precision medicine in predicting cutaneous squamous cell carcinoma risk among solid organ transplant recipients.

Nguyen MO, Nguyen HT, Asgari MM.

Br J Dermatol. 2017 Oct;177(4):901-902. doi: 10.1111/bjd.15886. No abstract available.

PMID:
29052902
15.

Risk prediction tools for keratinocyte carcinoma after solid organ transplantation: a review of the literature.

Lowenstein SE, Garrett G, Toland AE, Jambusaria-Pahlajani A, Asgari MM, Green A, Engels EA, Arron ST; National Cancer Institute Keratinocyte Carcinoma Consortium.

Br J Dermatol. 2017 Nov;177(5):1202-1207. doi: 10.1111/bjd.15889. Epub 2017 Sep 26. Review.

PMID:
28952162
16.

Prior authorizations for dermatologic medications: An American Academy of Dermatology survey of US dermatology providers and staff.

Secrest AM, Asgari MM, Kourosh AS, Barbieri JS, Albrecht J; American Academy of Dermatology Drug Pricing and Transparency Task Force.

J Am Acad Dermatol. 2017 Oct;77(4):784-786. doi: 10.1016/j.jaad.2017.05.008. No abstract available.

PMID:
28917469
17.

Serious infections among a large cohort of subjects with systemically treated psoriasis.

Dobry AS, Quesenberry CP, Ray GT, Geier JL, Asgari MM.

J Am Acad Dermatol. 2017 Nov;77(5):838-844. doi: 10.1016/j.jaad.2017.07.047. Epub 2017 Sep 13.

18.

Research Techniques Made Simple: An Introduction to Use and Analysis of Big Data in Dermatology.

Wehner MR, Levandoski KA, Kulldorff M, Asgari MM.

J Invest Dermatol. 2017 Aug;137(8):e153-e158. doi: 10.1016/j.jid.2017.04.019. Review.

PMID:
28735616
19.

Association of Multiple Primary Skin Cancers With Human Immunodeficiency Virus Infection, CD4 Count, and Viral Load.

Asgari MM, Ray GT, Quesenberry CP Jr, Katz KA, Silverberg MJ.

JAMA Dermatol. 2017 Sep 1;153(9):892-896. doi: 10.1001/jamadermatol.2017.1716.

PMID:
28700773
20.

Association between Lithium Use and Melanoma Risk and Mortality: A Population-Based Study.

Asgari MM, Chien AJ, Tsai AL, Fireman B, Quesenberry CP Jr.

J Invest Dermatol. 2017 Oct;137(10):2087-2091. doi: 10.1016/j.jid.2017.06.002. Epub 2017 Jun 17.

PMID:
28629629
21.

Parental Support for Age-based Indoor Tanning Restrictions.

Gilkey MB, Mays D, Asgari MM, Kornides ML, McRee AL.

Am J Prev Med. 2017 Oct;53(4):473-480. doi: 10.1016/j.amepre.2017.03.011. Epub 2017 May 15.

PMID:
28522236
22.

Prognostic factors and survival in acral lentiginous melanoma.

Asgari MM, Shen L, Sokil MM, Yeh I, Jorgenson E.

Br J Dermatol. 2017 Aug;177(2):428-435. doi: 10.1111/bjd.15600. Epub 2017 Jul 28.

PMID:
28432682
23.

Community-Based Practice Variations in Topical Treatment of Actinic Keratoses.

Storer M, Zhu Z, Sokil M, Ford M, Neugebauer R, Asgari MM.

JAMA Dermatol. 2017 May 1;153(5):468-470. doi: 10.1001/jamadermatol.2016.6251. No abstract available.

24.

Hypertrophic lichen planus mimicking squamous cell carcinoma: The importance of clinicopathologic correlation.

Levandoski KA, Nazarian RM, Asgari MM.

JAAD Case Rep. 2017 Mar 21;3(2):151-154. doi: 10.1016/j.jdcr.2017.01.020. eCollection 2017 Mar. No abstract available.

25.

Low Maternal Prenatal 25-Hydroxyvitamin D Blood Levels Are Associated with Childhood Atopic Dermatitis.

Blomberg M, Rifas-Shiman SL, Camargo CA Jr, Gold DR, Asgari MM, Thyssen JP, Litonjua AA, Gillman MW, Oken E.

J Invest Dermatol. 2017 Jun;137(6):1380-1384. doi: 10.1016/j.jid.2017.01.029. Epub 2017 Feb 12. No abstract available.

26.

Cutaneous squamous cell cancer (cSCC) risk and the human leukocyte antigen (HLA) system.

Yesantharao P, Wang W, Ioannidis NM, Demehri S, Whittemore AS, Asgari MM.

Hum Immunol. 2017 Apr;78(4):327-335. doi: 10.1016/j.humimm.2017.02.002. Epub 2017 Feb 7. Review.

27.

Malignancy rates in a large cohort of patients with systemically treated psoriasis in a managed care population.

Asgari MM, Ray GT, Geier JL, Quesenberry CP.

J Am Acad Dermatol. 2017 Apr;76(4):632-638. doi: 10.1016/j.jaad.2016.10.006. Epub 2017 Feb 3.

PMID:
28162854
28.

Polyomavirus-Negative Merkel Cell Carcinoma: A More Aggressive Subtype Based on Analysis of 282 Cases Using Multimodal Tumor Virus Detection.

Moshiri AS, Doumani R, Yelistratova L, Blom A, Lachance K, Shinohara MM, Delaney M, Chang O, McArdle S, Thomas H, Asgari MM, Huang ML, Schwartz SM, Nghiem P.

J Invest Dermatol. 2017 Apr;137(4):819-827. doi: 10.1016/j.jid.2016.10.028. Epub 2016 Nov 1.

29.

A GWAS of Cutaneous Squamous Cell Carcinoma-Letter.

Whittemore AS, Wang W, Jorgenson E, Asgari MM.

Cancer Epidemiol Biomarkers Prev. 2016 Nov;25(11):1534. No abstract available.

30.

Utility and Limitations of Large Population-Based Data for Skin Cancer Outcomes.

Asgari MM.

J Invest Dermatol. 2016 Nov;136(11):2128-2130. doi: 10.1016/j.jid.2016.07.031. Review.

31.

IRF4 Polymorphism Is Associated with Cutaneous Squamous Cell Carcinoma in Organ Transplant Recipients: A Pigment-Independent Phenomenon.

Asgari MM, Toland AE, Arron ST.

J Invest Dermatol. 2017 Jan;137(1):251-253. doi: 10.1016/j.jid.2016.07.038. Epub 2016 Aug 24. No abstract available.

32.

Diagnostic Prevalence of Ankylosing Spondylitis Using Computerized Health Care Data, 1996 to 2009: Underrecognition in a US Health Care Setting.

Curtis JR, Harrold LR, Asgari MM, Deodhar A, Salman C, Gelfand JM, Wu JJ, Herrinton LJ.

Perm J. 2016 Fall;20(4):4-10. doi: 10.7812/TPP/15-151. Epub 2016 Jul 29.

33.

Geographic Clusters of Basal Cell Carcinoma in a Northern California Health Plan Population.

Ray GT, Kulldorff M, Asgari MM.

JAMA Dermatol. 2016 Nov 1;152(11):1218-1224. doi: 10.1001/jamadermatol.2016.2536.

PMID:
27439152
34.

The state and consequences of dermatology drug prices in the United States.

Albrecht J, Lebwohl M, Asgari MM, Bennett DD, Cook A, Evans CC, Green LJ, Hodge JA, Kourosh AS, Maloney ME, Howard LM, Olsen EA, Rosenberg SP, Rubin A, Stough DB, Taylor SC, Brod BA.

J Am Acad Dermatol. 2016 Sep;75(3):603-605. doi: 10.1016/j.jaad.2016.03.053. Epub 2016 Jul 13. No abstract available.

PMID:
27423978
35.

Paraneoplastic syndromes (PNS) associated with Merkel cell carcinoma (MCC): A case series of 8 patients highlighting different clinical manifestations.

Iyer JG, Parvathaneni K, Bhatia S, Tarabadkar ES, Blom A, Doumani R, McKenzie J, Asgari MM, Nghiem P.

J Am Acad Dermatol. 2016 Sep;75(3):541-547. doi: 10.1016/j.jaad.2016.04.040. Epub 2016 May 11.

36.

Identification of Susceptibility Loci for Cutaneous Squamous Cell Carcinoma.

Asgari MM, Wang W, Ioannidis NM, Itnyre J, Hoffmann T, Jorgenson E, Whittemore AS.

J Invest Dermatol. 2016 May;136(5):930-7. doi: 10.1016/j.jid.2016.01.013. Epub 2016 Jan 29.

37.

Providers' Experiences with a Melanoma Web-Based Course: a Discussion on Barriers and Intentions.

Jiang AJ, Eide MJ, Alexander GL, Altschuler A, Asgari MM, Geller AC, Fletcher SW, Halpern AC, Weinstock MA.

J Cancer Educ. 2017 Jun;32(2):272-279. doi: 10.1007/s13187-015-0910-4.

38.

Voriconazole Exposure and Risk of Cutaneous Squamous Cell Carcinoma, Aspergillus Colonization, Invasive Aspergillosis and Death in Lung Transplant Recipients.

Mansh M, Binstock M, Williams K, Hafeez F, Kim J, Glidden D, Boettger R, Hays S, Kukreja J, Golden J, Asgari MM, Chin-Hong P, Singer JP, Arron ST.

Am J Transplant. 2016 Jan;16(1):262-70. doi: 10.1111/ajt.13431. Epub 2015 Sep 3.

39.

Multiple primary melanomas among 16,570 patients with melanoma diagnosed at Kaiser Permanente Northern California, 1996 to 2011.

Moore MM, Geller AC, Warton EM, Schwalbe J, Asgari MM.

J Am Acad Dermatol. 2015 Oct;73(4):630-6. doi: 10.1016/j.jaad.2015.06.059. Epub 2015 Aug 19.

PMID:
26298295
40.

Sirolimus use and risk of cutaneous squamous cell carcinoma (SCC) in solid organ transplant recipients (SOTRs).

Asgari MM, Arron ST, Warton EM, Quesenberry CP Jr, Weisshaar D.

J Am Acad Dermatol. 2015 Sep;73(3):444-50. doi: 10.1016/j.jaad.2015.05.029. Epub 2015 Jun 30.

PMID:
26138646
41.

Trends in Basal Cell Carcinoma Incidence and Identification of High-Risk Subgroups, 1998-2012.

Asgari MM, Moffet HH, Ray GT, Quesenberry CP.

JAMA Dermatol. 2015 Sep;151(9):976-81. doi: 10.1001/jamadermatol.2015.1188.

PMID:
26039887
42.

Identification of Stevens-Johnson syndrome and toxic epidermal necrolysis in electronic health record databases.

Davis RL, Gallagher MA, Asgari MM, Eide MJ, Margolis DJ, Macy E, Burmester JK, Selvam N, Boscarino JA, Cromwell LF, Feigelson HS, Kuntz JL, Pawloski PA, Penfold RB, Raebel MA, Sridhar G, Wu A, La Grenade LA, Pacanowski MA, Pinheiro SP.

Pharmacoepidemiol Drug Saf. 2015 Jul;24(7):684-92. doi: 10.1002/pds.3778. Epub 2015 Apr 24.

PMID:
25914229
43.

Family history of skin cancer is associated with increased risk of cutaneous squamous cell carcinoma.

Asgari MM, Warton EM, Whittemore AS.

Dermatol Surg. 2015 Apr;41(4):481-6. doi: 10.1097/DSS.0000000000000292.

44.

Imputation of the rare HOXB13 G84E mutation and cancer risk in a large population-based cohort.

Hoffmann TJ, Sakoda LC, Shen L, Jorgenson E, Habel LA, Liu J, Kvale MN, Asgari MM, Banda Y, Corley D, Kushi LH, Quesenberry CP Jr, Schaefer C, Van Den Eeden SK, Risch N, Witte JS.

PLoS Genet. 2015 Jan 28;11(1):e1004930. doi: 10.1371/journal.pgen.1004930. eCollection 2015 Jan. Erratum in: PLoS Genet. 2015 Apr;11(4):e1005114. PLoS Genet. 2015 Jun;11(6):e1005362.

45.

CD8+ lymphocyte intratumoral infiltration as a stage-independent predictor of Merkel cell carcinoma survival: a population-based study.

Paulson KG, Iyer JG, Simonson WT, Blom A, Thibodeau RM, Schmidt M, Pietromonaco S, Sokil M, Warton EM, Asgari MM, Nghiem P.

Am J Clin Pathol. 2014 Oct;142(4):452-8. doi: 10.1309/AJCPIKDZM39CRPNC.

46.

Sebotropic eruption associated with use of oral kava kava supplement.

Huynh JC, Asgari MM, Moore MM.

Clin Exp Dermatol. 2014 Oct;39(7):816-8. doi: 10.1111/ced.12439.

PMID:
25214405
47.

Comparing characteristics of melanoma cases arising in health maintenance organizations with state and national registries.

Asgari MM, Eide MJ, Warton M, Fletcher SW.

Melanoma Res. 2014 Aug;24(4):381-7. doi: 10.1097/CMR.0000000000000087.

PMID:
24858660
48.

Risk of subsequent cutaneous squamous cell carcinoma in patients with melanoma.

Asgari MM, Warton EM, Quesenberry CP, Koralek DO, Taylor M.

J Am Acad Dermatol. 2014 Sep;71(3):521-8. doi: 10.1016/j.jaad.2014.04.019. Epub 2014 May 21.

PMID:
24856040
49.

Effect of host, tumor, diagnostic, and treatment variables on outcomes in a large cohort with Merkel cell carcinoma.

Asgari MM, Sokil MM, Warton EM, Iyer J, Paulson KG, Nghiem P.

JAMA Dermatol. 2014 Jul;150(7):716-23. doi: 10.1001/jamadermatol.2013.8116.

50.

Initiation of TNF inhibitor therapy and change in physiologic measures in psoriasis.

Wu JJ, Liu L, Asgari MM, Curtis JR, Harrold L, Salman C, Herrinton LJ.

J Eur Acad Dermatol Venereol. 2014 Oct;28(10):1380-7. doi: 10.1111/jdv.12296. Epub 2013 Nov 7.

Supplemental Content

Loading ...
Support Center